StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
DCTTR.IS$12.30+0.08%
Fair $12.30+0.0%

DCTTR.IS

DCTTR.IS

Financial Services / Capital MarketsIstanbul

$12.30

+0.01 (+0.08%)

Fairly Valued+0.0%Fair Value $12.30Fund rank 23/100 · Data gapFallback financials|
SA 22/D
F-Score: 1/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 5/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

22/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is -12.0%, below the 5% threshold
Thesis & Journal · DCTTR.ISLocal privado en este navegador · DCTTR.IS
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.8B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-12.0%

↓

Gross Margin

13.7%

↓

Debt/Equity

0.66

↑
52-Week Range$12
$7$15

TradingView lightweight chart

DCTTR.IS price, volumen y niveles de valoración

Último $12.30Periodo +139.6%
Fair value: $12.30

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-4.5%

FCF CAGR

—

FCF margin

-16.1%

FCF / Net income

3.64x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.71B · net income $-119.7M · FCF $-435.6M

2022-FY → 2025-FY

Gross margin

13.7%+10.2% pts

Operating margin

5.9%+4.1% pts

Net margin

-4.4%-5.8% pts

FCF margin

-16.1%-17.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.71B$2.71B$3.28B$2.22B$3.11B
Net Income$-119.7M$-119.7M$-56.4M$11.1M$44.4M
EBITDA$-10.7M$-10.7M$35.7M$163.3M$76.9M
EPS-0.30-0.30-0.170.030.11
Gross Margin13.7%13.7%-1.3%4.2%3.4%
Operating Margin5.9%5.9%-7.1%1.6%1.8%
Net Margin-4.4%-4.4%-1.7%0.5%1.4%
Balance Sheet
Debt/Equity0.660.660.351.760.61
Current Ratio2.472.47———
Cash Flow
Free Cash Flow$-435.6M$-435.6M$461.8M$-398.5M$31.7M
Returns
ROE-12.0%-12.0%-5.5%3.0%15.3%
Valuation
EV/EBITDA——97.71——
P/B4.954.953.21——
Growth & Yield
Revenue Growth-17.5%-17.5%48.1%-28.6%—
EPS Growth-78.0%-78.0%-685.4%-75.0%—
Dividend Yield0.5%0.5%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -6.1%

Total return

-6.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.17 → -0.30

Residual

-6.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.5%
Residual / FX / buybacks / cross-term-6.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.